A comparative study of a preservative-free latanoprost cationic emulsion (catioprost) and a BAK-preserved latanoprost solution in animal models
Daull P., Buggage R., Lambert G., Faure M.-O., Serle J., Wang R.-F., Garrigue J.-S.
View publication
-
Therapeutic Area
Glaucoma
-
Technology
Pharmacology
-
Categories
Preclinical development
-
Affiliations
Novagali Pharma, Bâtiment Genavenir IV, 1, rue Pierre Fontaine, Evry cedex, F-91058, France; Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY, United States